© Copyright 2026 American Medical Association. All rights reserved.
A live attenuated human rotavirus vaccine, designated as RV1, is administered orally in a two-dose schedule. This vaccine is specifically designed to provide long-term immunity against rotavirus, a highly contagious virus that is a leading cause of severe gastroenteritis in infants and young children. Unlike immune globulins, which offer only short-term, passive immunity, vaccines like RV1 stimulate the recipient's immune system to produce its own antibodies. This process involves exposing the immune system to a modified version of the virus, which helps the body learn to recognize and combat the actual virus in the future. Rotavirus infection is prevalent, with nearly every child in the United States experiencing it by the age of five, often resulting in multiple episodes of vomiting and severe diarrhea that may necessitate hospitalization. The RV1 vaccine contains a weakened strain of the rotavirus, ensuring safety while effectively preparing the immune system to respond to future infections. It is important to note that this CPT® code specifically reports the supply of the vaccine and does not include the oral administration of the vaccine itself.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.